全文获取类型
收费全文 | 1251篇 |
免费 | 147篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 38篇 |
妇产科学 | 30篇 |
基础医学 | 150篇 |
口腔科学 | 40篇 |
临床医学 | 125篇 |
内科学 | 268篇 |
皮肤病学 | 12篇 |
神经病学 | 52篇 |
特种医学 | 26篇 |
外科学 | 220篇 |
综合类 | 75篇 |
预防医学 | 87篇 |
眼科学 | 30篇 |
药学 | 80篇 |
1篇 | |
中国医学 | 26篇 |
肿瘤学 | 142篇 |
出版年
2024年 | 3篇 |
2023年 | 10篇 |
2022年 | 21篇 |
2021年 | 29篇 |
2020年 | 22篇 |
2019年 | 47篇 |
2018年 | 51篇 |
2017年 | 42篇 |
2016年 | 59篇 |
2015年 | 48篇 |
2014年 | 51篇 |
2013年 | 80篇 |
2012年 | 79篇 |
2011年 | 80篇 |
2010年 | 77篇 |
2009年 | 58篇 |
2008年 | 91篇 |
2007年 | 64篇 |
2006年 | 52篇 |
2005年 | 61篇 |
2004年 | 52篇 |
2003年 | 39篇 |
2002年 | 45篇 |
2001年 | 30篇 |
2000年 | 26篇 |
1999年 | 30篇 |
1998年 | 10篇 |
1997年 | 7篇 |
1996年 | 15篇 |
1995年 | 12篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1992年 | 5篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1980年 | 3篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1971年 | 4篇 |
1968年 | 3篇 |
1966年 | 6篇 |
排序方式: 共有1417条查询结果,搜索用时 15 毫秒
11.
用宿主防御指数辅助诊断中医虚证和不同辩证虚证的探讨 总被引:5,自引:0,他引:5
以中医学“虚证”及不同辩证虚证为研究对象,以宿主防御指数为研究总指标,开展了营养学和免疫学的多指标观察,并借助于医学统计学的理论和方法,尝试对中医学“虚证”的诊断。结果显示;虚证患者与正常人相比营养条件差,免疫功能氏下,主要表现为细胞免疫功能低下和免疫调节紊乱,补体主要成分降低,将这些评价指标代入计算机进行逐步判断分析,得出可以判别正常人,气阳虚患者,血阴虚患者的方程式,方程式判别能力F=3(P〈 相似文献
12.
Van der Veen Jacoba Te Wierik Gerrit H. P. Van der Wal Liesbeth Eissens Anko C. Lerk Coenraad F. 《Pharmaceutical research》1994,11(4):499-502
Amylodextrin is a linear dextrin and can be produced by enzymatic hydrolysis of the -1,6 glycosidic bonds of amylopectin. Tablets compacted from pure amylodextrin showed good binding properties and did not disintegrate in aqueous media. Extended and decreasing drug release rates were found for tablets of 300 mg with a diameter of 9 mm containing 70% amylodextrin and 30% theophylline monohydrate, when compacted at 5 kN. Almost-constant drug release rates were obtained for these tablets when compacted at 10 or 15 kN. Nearly constant drug release rates were also shown for amylodextrin tablets with a drug load up to 75% compacted at 10 kN. Both release rate and release profile could be adjusted by selecting tablet thickness and incorporation of either lactose as a highly soluble excipient or talc as a hydrophobic excipient. 相似文献
13.
Objectives
To compare safety and efficacy of fascial versus vaginal wall slings in the management of women with intrinsic sphincter deficiency (ISD).Methods
The hospital and office records of 79 consecutive women with ISD were retrospectively analyzed from January 1991 to September 1995. There were 43 fascial slings (group A) and 36 vaginal wall slings (group B). Parameter of evaluation included efficacy based on postoperative presence of stress or urge incontinence and number of pads used, complications, and miscellaneous factors, including length of catheterization time, length of hospitalization, quantity of analgesics used, and loss of work days.Results
Baseline clinical and urodynamic data were the same for both groups. Pad use decreased from 6.9 to 0.6 for group A and from 5.7 to 0.3 for group B. Persistent stress and urge incontinence was present in 5% and 16% of group A patients and in 3% and 11 % of group B patients, respectively. Group A (89%) and group B (94%) patients were either very satisfied or satisfied with their surgical outcome. The operative time, hospital days, and days lost from work for group B patients (42.3 ± 13.4 minutes, 1.4 ± 0.9 days, 18.4 ±3.2 days, respectively) were significantly lower than for group A patients (84.2 ± 17.8 minutes, 3.7 ± 1.9 days, 28.4 ±7.8 days, respectively).Conclusions
Both fascial and vaginal wall slings are effective in treating women with ISD. However, the use of vaginal wall slings resulted in significantly shorter hospital stay, decreased catheterization time, decreased use of analgesics, and decreased loss of days of work compared with fascial slings. Therefore, the vaginal wall sling should be the preferred surgical method of treating intrinsic sphincter deficiency. 相似文献14.
van Kleef EM Zurcher C Oussoren YG Te Poele JA van der Valk MA Niemer-Tucker MM van der Hage MH Broerse JJ Robbins ME Johnston DA Stewart FA 《International journal of radiation biology》2000,76(5):641-648
PURPOSE: To investigate the long-term effects of total-body irradiation (TBI) on kidneys in non-human primates. METHODS AND MATERIALS: The kidneys of Rhesus monkeys were histologically examined at 6-8 years after TBI with low single doses of 4.5-8.5Gy or two fractions of 5.4Gy. The kidneys of age-matched non-irradiated monkeys served as controls. Irradiation was performed on adult monkeys aged about 3 years; 6-8 years later animals were sacrificed and the kidneys removed and processed for histology. A semi-quantitative scoring system was used to evaluate overall histological damage. Glomerular changes were also morphometrically analysed according to previously published criteria. In selected dose groups (pro)thrombotic and inflammatory changes were investigated by immunostaining cryosections with antibodies against von Willebrand factor (vWF), leukocytes and macrophages. RESULTS: Histological changes were generally mild and only seen in kidneys irradiated with doses higher than 7 Gy. Glomerular changes were characterized by increased mesangial matrix and capillary dilatation. Tubulo-interstitial changes included hypercellularity, fibrosis and mild tubular atrophy. The mean glomerular area expressing vWF protein in the irradiated kidneys was not different from that in the age-matched controls. Numbers of infiltrating leukocytes were not significantly different between irradiated kidneys and controls. However, slightly increased numbers of macrophages were present in the renal cortex after irradiation. CONCLUSIONS: Renal damage after TBI of Rhesus monkeys with single doses of 4.5-8.5 Gy or two fractions of 5.4 Gy was mild, even after follow-up times of 6-8 years. 相似文献
15.
目的回顾性分析本科自2004年8月~2005年6月共489例因肾脏疾病行活检的病理资料,总结重庆地区肾脏疾病的临床病理类型特点。方法参照WHO肾小球疾病组织学分型修订方案(1982年及1995年),对每1例患者均进行临床病理讨论,由病理医师和临床医师结合临床资料、实验室检查结果、免疫病理及超微结构改变特点,共同探讨、明确病理诊断及拟定相应的治疗措施。结果本组489例肾活检组织中有4例为移植肾,其余485例为固有肾脏。患者年龄8~72岁,平均(32±16)岁;男女之比0.72∶1。除移植肾活检者,本组中原发性肾小球疾病占73.40%,继发性肾小球疾病占17.32%,先天性肾小球疾病占0.21%,终末期肾脏疾病占4.12%,小管间质性疾病占4.95%。原发性肾小球疾病以IgA肾病居多(27.20%),其次分别为系膜增生性肾小球肾炎(21.27%),膜性肾病(8.18%),FSGS(6.13%)。继发性肾脏病中以狼疮性肾炎多见(9.41%),其次是紫癜性肾炎(3.27%)。急性肾衰起病者仍以急性肾小管坏死多见,在急性间质性肾病中与药物相关的也不可忽视。肾穿刺并发症少,最严重的是肉眼血尿,余无特殊并发症。结论重庆地区原发性肾小球肾炎仍是最常见的肾小球疾病,其中以IgA肾病和系膜增生性肾小球肾炎最常见,继发性肾脏病以狼疮性肾炎多见,女性占绝对优势。急性肾衰的病理变化多样。肾活检的适应证可以扩大。 相似文献
16.
Fan‐Chen Ku Chi‐Ren Tsai Jiaan‐ Der Wang Chih Hsiang Wang Te‐Kau Chang Wen‐Li Hwang 《European journal of haematology》2013,90(1):25-30
Primary immune thrombocytopenia (ITP) of childhood is an autoimmune disease characterized by abnormally increased destruction of platelets and decreased megakaryopoiesis. Stromal‐derived factor‐1 (SDF‐1) plays a role in megakaryopoiesis and may be involved in the pathogenesis of ITP. Five single nucleotide polymorphisms (SNPs) of the SDF‐1 gene, including rs1801157, rs2839693, rs2297630, rs1065297, and rs266085, were assessed in 100 children with ITP and 126 healthy controls. The genotypes were analyzed by tetra ARMS polymerase chain reaction and confirmed by direct sequencing. Compared with controls, the rs2839693 A/A and rs266085 C/T genotypes were decreased in ITP patients (P = 0.004 and 0.007, respectively). The odds ratios of the latter genotypes were 0.48, 95% CI 0.28–0.82. Further analysis of the relationship between SDF‐1 polymorphisms and clinical features showed that rs2297630 A/G was associated with protection from chronicity (P = 0.002; OR, 0.07; 95% CI, 0.01–0.61) and steroid dependence (P = 0.007; OR, 0.10; 95% CI, 0.01–0.84) in ITP patients. However, rs266085 genotype C/C was associated with risk of steroid dependence (P = 0.012, OR 3.87, 95% CI 1.27–11.77). The findings of this study suggest that SDF‐1 gene variations may be associated with the occurrence and prognosis of childhood ITP. 相似文献
17.
18.
19.
S. A. Kaplan D. E. Chung R. K. Lee S. Scofield A. E. Te 《International journal of clinical practice》2012,66(11):1052-1055
Objective: We evaluated 5‐year safety, efficacy and prostate volume data from BPH patients treated with finasteride or dutasteride. Methods: A retrospective analysis of 378 consecutive men treated with 5α‐reductase inhibitor monotherapy between January 2004 and September 2009 (197 on finasteride and 211 on dutasteride) in a single clinic was performed. Efficacy assessments included International Prostate Symptom Score (IPSS), peak urinary flow rate (Qmax), postvoid residual urine volume (PVR), prostate‐specific antigen (PSA) and prostate volume (PV). Safety assessments included International Index of Erectile Function (IIEF) and adverse events. Patients were evaluated at 3 months, 1 year and yearly thereafter. Results: Mean age of the group was 58.7 ± 6.7 years. Maintenance of therapy at 5 years was 57.4% and 42.5% for the finasteride and dutasteride groups respectively. Changes in IPSS, Qmax, PVR, PV and PSA were similar for both groups at 5 years. The incidence of erectile dysfunction, ejaculatory dysfunction and decreased libido resulting in discontinuation from therapy was significantly (p < 0.01) higher in the dutasteride (5.1%, 2.4%, 2.7% respectively) compared with the finasteride (2.1%, 1.8%, 1.4% respectively) group. In addition, the incidence of self‐reported breast tenderness and/or enlargement was significantly (p < 0.01) greater in the dutasteride (3.5%) compared with the finasteride (1.2%) group. Conclusions: In this retrospective analysis of data from consecutive patients treated at a single clinic, both finasteride and dutasteride were effective therapies for the management of lower urinary tract symptoms. However, dutasteride resulted in significantly more sexual side effects and breast complications than finasteride. 相似文献
20.